Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancer

被引:0
|
作者
Haruhiko Yamazaki
Tomoyuki Yokose
Hiroyuki Hayashi
Hiroyuki Iwasaki
Sachie Osanai
Nobuyasu Suganuma
Hirotaka Nakayama
Katsuhiko Masudo
Yasushi Rino
Munetaka Masuda
机构
[1] Kanagawa Cancer Center,Department of Breast and Endocrine Surgery
[2] Kanagawa Cancer Center,Department of Pathology
[3] Yokohama City University Medical Center,Department of Breast and Thyroid Surgery
[4] Yokohama City University School of Medicine,Department of Surgery
来源
关键词
Thyroid cancer; Molecular biology; Clinical research; Lenvatinib; Vascular endothelial growth factor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:649 / 654
页数:5
相关论文
共 50 条
  • [41] Immunohistochemical Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor in Canine Cutaneous Fibrosarcomas
    Al-Dissi, A. N.
    Haines, D. M.
    Singh, B.
    Kidney, B. A.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2009, 141 (04) : 229 - 236
  • [42] Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer
    Schiff, BA
    McMurphy, AB
    Jasser, SA
    Younes, MN
    Doan, D
    Yigitbasi, OG
    Kim, SW
    Zhou, G
    Mandal, M
    Bekele, BN
    Holsinger, FC
    Sherman, SI
    Yeung, SC
    El-Naggar, AK
    Myers, JN
    CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8594 - 8602
  • [43] The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults
    Fenton, C
    Patel, A
    Dinauer, C
    Robie, DK
    Tuttle, RM
    Francis, GL
    THYROID, 2000, 10 (04) : 349 - 357
  • [44] Vascular endothelial growth factor gene polymorphisms in thyroid cancer
    Hsiao, Pi-Jung
    Lu, Ming-Ying
    Chiang, Feng-Yu
    Shin, Shyi-Jang
    Tai, Yu-Da
    Juo, Suh-Hang Hank
    JOURNAL OF ENDOCRINOLOGY, 2007, 195 (02) : 265 - 270
  • [45] Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance
    Wimberger, Pauline
    Chebouti, Issam
    Kasimir-Bauer, Sabine
    Lachmann, Robert
    Kuhlisch, Eberhard
    Kimmig, Rainer
    Sueleyman, Erguen
    Kuhlmann, Jan Dominik
    GYNECOLOGIC ONCOLOGY, 2014, 133 (03) : 467 - 472
  • [46] Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance
    Ranjbar, Reza
    Nejatollahi, Foroogh
    Ahmadi, Ahmad Sina Nedaei
    Hafezi, Hossein
    Safaie, Akbar
    IRANIAN JOURNAL OF CANCER PREVENTION, 2015, 8 (04)
  • [47] Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer
    Doi, Yosuke
    Yashiro, Masakazu
    Yamada, Nobuya
    Amano, Ryosuke
    Ohira, Go
    Komoto, Masahiro
    Noda, Satoru
    Kashiwagi, Shinichiro
    Kato, Yukihiro
    Fuyuhiro, Yuhiko
    Hirakawa, Kosei
    CANCER SCIENCE, 2010, 101 (06) : 1529 - 1535
  • [48] Cyclo-oxygenase-2 and vascular endothelial growth factor expression in colorectal cancer patients
    Hedaya, Mohammed S.
    Helmy, Ahmed Hazem
    Ezzat, Houssin
    Hammam, Olfat
    EGYPTIAN JOURNAL OF SURGERY, 2015, 34 (01): : 35 - 40
  • [49] Vascular endothelial growth factor-A, vascular endothelial growth factor receptor-2 and angiopoietin-2 expression in the mouse choroid plexuses
    Nico, B
    Mangieri, D
    Corsi, P
    De Giorgis, M
    Vacca, A
    Roncali, L
    Ribatti, D
    BRAIN RESEARCH, 2004, 1013 (02) : 256 - 259
  • [50] Clinical significance of vascular, endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma
    Arinaga, M
    Noguchi, T
    Takeno, S
    Chujo, M
    Miura, T
    Uchida, Y
    CANCER, 2003, 97 (02) : 457 - 464